Clinical Study Of Buyi Qubi Decoction Combined With Daytime Transforaminal Endoscopic Discectomy For Lumbar Disc Herniation Of Deficiency Of Liver And Kidney

Objective:This study aims to investigate the effect of traditional Chinese medicine preparation and further explore its practical value in clinical practice by observing the short-term clinical effect of Buyi Qubi Decoction combined with daytime foraminal surgery in the treatment of lumbar disc herniation of liver and kidney deficiency.To provide more effective ideas and methods for clinical exploration and treatment of lumbar disc herniation.Methods:A total of 68 patients diagnosed with lumbar disc herniation of liver and kidney deficiency type in Zhengzhou Orthopaedic Hospital from January 2019 to October2020 were included in this study,the patients signed the "informed consent" and were numbered according to the order of admission.According to the random number table method,they were randomly divided into the experimental group(Buyi Qubi Decoction combined with daytime foraminal endoscopic group)and the control group(daytime foraminal endoscopic group alone),with 34 cases in each group.To observe the clinical effect of Buyi Qubi Decoction combined with daytime foraminal scope in the treatment of lumbar intervertebral disc herniation of liver and kidney deficiency type by comparing the clinical observation indexes.According to the visual analogue scale(VAS),Oswestry disability index(ODI)score,nylon cord test,the modified Macnab score of lower limb,compared two groups of patients with preoperative and postoperative 1 week,1 month,3 months after operation,postoperative follow-up after 6 months and the last level of pain,lumbar function recovery,limb sensory recovery,compared two groups in the incidence of adverse events.SPSS 21.0 software was used for statistical data analysis.Results:1.A total of 70 patients were included,including 2 cases of abscission.A total of68 patients were eventually included,including 34 in the experimental group and 34 in the control group.All patients completed follow-up as required.2.There was no statistical significance in baseline data(gender,age,course of disease,responsibility segment,etc.)between the two groups(P>0.05),indicating comparability.3.In back pain VAS score,lumbar ODI score: group,all after contrast decreases,and the difference has statistical significance(P<0.05),compare the preoperative and postoperative June between groups had no statistical difference(P>0.05),postoperative 1 week,1 month after surgery,postoperative march score in test group were lower than the control group,and the difference is statistically significant(P<0.05);in terms of leg pain VAS scores than those in the group with January after 1week and score no difference(P>0.05),the rest of the control group,experimental group preoperative and postoperative after 1 week,1 month,3 months after operation,postoperative June decreases(P<0.05),group comparison between preoperative and postoperative June had no statistical difference(P>0.05),postoperative 1 week,1month after surgery,postoperative march score in test group were lower than the control group,and the difference is statistically significant(P<0.05);In lower limb nylon rope experiment score aspects: group contrast group within 1 week after operation,postoperative 1 month higher score than previous period(P<0.05),June score 3 months after operation,postoperative basically stable,no statistical difference(P>0.05),control group in preoperative and postoperative 1 week,1 month after operation,postoperative march score with the extension of time gradually rise,all the previous statistically significant(P<0.05);There was no significant difference in the scores between 3 and 6 months after surgery(P>0.05).There was no statistical difference between groups before surgery,3 months after surgery,and 6 months after surgery(P>0.05).The scores of the test group were higher than those of the control group 1 week and 1 month after surgery,and the difference was statistically significant(P<0.05).4.Evaluation of efficacy of modified Macnab: At the last follow-up 6 months after surgery,efficacy evaluation of the two groups: Comparison of efficacy of Macnab between the test group(excellent 29 cases,good 4 cases,fair 1 case,poor 0cases)and the control group(excellent 26 cases,good 6 cases,fair 2 cases,poor 0cases)showed no statistical significance(P>0.05).There was no statistical significance in the good rate between the two groups(P>0.05).Conclusion:1.Both Buyi Qubi Decoction combined with diurnal foraminal endoscopy and diurnal foraminal endoscopy alone for the treatment of lumbar disc herniation of liver and kidney deficiency can significantly relieve the patients’ lumbago and leg pain and lower limb numbness,and promote the functional recovery of the lumbar spine,which are both effective treatment methods;2.Combined oral Buyi Qubi Decoction for 3 months after daytime foraminal surgery can accelerate the recovery of residual pain in the early postoperative lower extremity,significantly improve the symptoms of lower extremity numbness,and promote the functional recovery of the lumbar spine,which is more advantageous than single surgical treatment;3.Buyi Qubi Decoction combined with daytime foraminal endoscopic surgery for the treatment of lumbar disc herniation has a certain positive significance and can accelerate the rapid recovery of patients,which is worthy of further promotion.